Baker Tilly Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,014	Closed	-$334K	–	292
2024 Q2	$334K	Sell	1,014 -2,919	-74%	-$1.03M	0.14%	177
2024 Q1	$1.56M	Buy	3,933 +46	+1%	+$17K	0.28%	84
2023 Q4	$1.37M	Buy	3,887 +18	+0.5%	+$6.37K	0.22%	103
2023 Q3	$1.45M	Sell	3,869 -476	-11%	-$184K	0.24%	90
2023 Q2	$1.66M	Sell	4,345 -190	-4%	-$67.9K	0.17%	126
2023 Q1	$1.57M	Buy	4,535 +213	+5%	+$62.2K	0.18%	125
2022 Q4	$1.02M	Buy	4,322 +670	+18%	+$159K	0.13%	184
2022 Q3	$899K	Sell	3,652 -5	-0.1%	-$1.52K	0.12%	183
2022 Q2	$1.11M	Buy	3,657 +385	+12%	+$125K	0.15%	148
2022 Q1	$1.34M	Sell	3,272 -111	-3%	-$43.5K	0.15%	141
2021 Q4	$1.59M	Buy	3,383 +500	+17%	+$215K	0.17%	125
2021 Q3	$1.22M	Buy	2,883 +1,062	+58%	+$448K	0.16%	128
2021 Q2	$654K	Buy	1,821 +285	+19%	+$94.2K	0.11%	216
2021 Q1	$433K	Buy	1,536 +243	+19%	+$69.5K	0.09%	276
2020 Q4	$366K	Buy	+1,293	New	+$363K	0.11%	198